Literature DB >> 24126603

Immunogenicity of hypothetical highly conserved proteins as novel antigens in Anaplasma marginale.

Pablo A Nuñez1, Rosalia Moretta, Paula Ruybal, Silvina Wilkowsky, Marisa D Farber.   

Abstract

Anaplasma marginale is a tick-transmitted Gram-negative intraerythrocytic bacterium and the etiological agent of bovine Anaplasmosis. Even though considerable research efforts have been undertaken, Anaplasmosis vaccine development remains a challenging field. Outer-membrane-specific antigens responsible for the ability of more complex immunogens could have a significant role in the protective response. Thus, the identification of outer-membrane antigens represents a major goal in the development of bacterial vaccines. Considering that 40 % of the annotated proteins in A. marginale remain as hypothetical, we selected three candidate antigens, AM1108, AM127, and AM216 based on experimental evidence, in silico structure prediction of β-barrel outer membrane, and orthology clustering. Sequence alignment and analysis demonstrated a high degree of conservation for the three proteins between the isolates from Argentina compared to the American strains. We confirmed the transcription of the three genes in the intraerythrocytic stage. AM1108 and AM216 recombinant proteins elicited specific T-cell response proliferation and a significant rise in TNF-α and IFN-γ transcript levels, respectively. Only AM1108 was able to be recognized by specific antibodies from infected bovines. This study allowed the identification of new candidate components of the outer-membrane fraction of A. marginale. Further studies will be required to analyze their potential as effective antigens for being included in rational vaccine strategies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24126603     DOI: 10.1007/s00284-013-0475-6

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  45 in total

1.  Ingenious gene generation.

Authors:  P F Meeus; A F Barbet
Journal:  Trends Microbiol       Date:  2001-08       Impact factor: 17.079

2.  Acute phase response in cattle infected with Anaplasma marginale.

Authors:  S Nazifi; S M Razavi; F Kaviani; E Rakhshandehroo
Journal:  Vet Microbiol       Date:  2011-08-31       Impact factor: 3.293

3.  Expression of Anaplasma marginale major surface protein 2 variants during persistent cyclic rickettsemia.

Authors:  D M French; T F McElwain; T C McGuire; G H Palmer
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Proteomic analysis of Neorickettsia sennetsu surface-exposed proteins and porin activity of the major surface protein P51.

Authors:  Kathryn Gibson; Yumi Kumagai; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2010-09-10       Impact factor: 3.490

5.  Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.

Authors:  Job E Lopez; Guy H Palmer; Kelly A Brayton; Michael J Dark; Stephanie E Leach; Wendy C Brown
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

6.  Vaccination with Anaplasma centrale: response after an experimental challenge with Anaplasma marginale.

Authors:  O S Anziani; H D Tarabla; C A Ford; C Galleto
Journal:  Trop Anim Health Prod       Date:  1987-05       Impact factor: 1.559

7.  The immunization-induced antibody response to the Anaplasma marginale major surface protein 2 and its association with protective immunity.

Authors:  Susan M Noh; Yan Zhuang; James E Futse; Wendy C Brown; Kelly A Brayton; Guy H Palmer
Journal:  Vaccine       Date:  2010-03-01       Impact factor: 3.641

8.  Genetic diversity of Anaplasma marginale in Argentina.

Authors:  Paula Ruybal; Rosalia Moretta; Andres Perez; Romina Petrigh; Patricia Zimmer; Elda Alcaraz; Ignacio Echaide; Susana Torioni de Echaide; Katherine M Kocan; Jose de la Fuente; Marisa Farber
Journal:  Vet Parasitol       Date:  2009-02-12       Impact factor: 2.738

9.  CD4(+) T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge.

Authors:  W C Brown; V Shkap; D Zhu; T C McGuire; W Tuo; T F McElwain; G H Palmer
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

10.  Determining the repertoire of immunodominant proteins via whole-genome amplification of intracellular pathogens.

Authors:  Michael J Dark; Anna M Lundgren; Anthony F Barbet
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

View more
  1 in total

Review 1.  Anaplasma marginale: Diversity, Virulence, and Vaccine Landscape through a Genomics Approach.

Authors:  Rosa Estela Quiroz-Castañeda; Itzel Amaro-Estrada; Sergio Darío Rodríguez-Camarillo
Journal:  Biomed Res Int       Date:  2016-08-17       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.